Spinal muscular atrophy drug subsidy 'set for adults'
Michael Tien, standing centre, hopes the new arrangement to widen the application of a subsidy to more spinal muscular atrophy patients can be implemented within months. Photo: RTHK
More Hong Kong patients suffering from spinal muscular atrophy (SMA) will be able to enjoy a government subsidy to control the symptoms of their disorder with two drugs, Roundtable lawmaker Michael Tien said.
Currently, only infants and children suffering from two types of SMA, a group of neuromuscular disorders, are entitled to government assistance to purchase the drugs – Nusinersen and Risdiplam.
The health authorities, Tien said on Friday, have recently given the green light for adult patients suffering from two other types of the disorder to apply for the subsidy as well.
Tien said he aims to push for the new arrangement to be implemented before his Legco term ends by the end of the year.
He also urged the government to refer to mainland data in vetting drugs in the future.
'Hong Kong experts, when they decide whether to use public money to help patients with a particular disease, look at their own research…they look at worldwide papers,' Tien said.
'My argument is that those [patients] are not of the same race as us, our blood types are different, our DNAs are different.
"Why can't the Hong Kong government look more at the mainland situation?'
Tien also said the newly introduced 1+ mechanism that speeds up registration of new drugs in Hong Kong will also facilitate the SAR in price negotiations with global pharmaceutical companies.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
RTHK
2 days ago
- RTHK
HKU gets early boost in race for medical students
HKU gets early boost in race for medical students Thirty-one of the 57 students accepted early for the University of Hong Kong's medical programme came through the School Nominations Direct Admission Scheme. Photo: RTHK The University of Hong Kong's faculty of medicine said on Monday it has already filled a sixth of its undergraduate programme enrolment quota for the upcoming academic year ahead of Wednesday's release of Diploma of Secondary Education (DSE) examination results. The 57 students received unconditional offers through different schemes, namely the School Nominations Direct Admission Scheme (SNDAS) and IB Diploma programme. It said 31 students were from the SNDAS – a program rolled out by the Education Bureau in the 2022-23 academic year. This was up from 21 and 24 students in 2023 and 2024, respectively. 'This is the third year that we have SNDAS students reading medicine,' said assistant dean Kenny Kwan. "Through the experience of the past two years, we are able to understand more about the criteria [that we need to set] for students being recommended by their schools and principals. 'We have more confidence that these students can excel in our medical school programme. "Through that we are able to increase the number of candidates." Kwan said one of them was from Minxin School in Guangzhou – which participated in the DSE examination for the first time. The faculty also said all 25 spots have been filled in its second-degree programme, which allows students to complete their studies in four years. It said more than 950 applications were received, with almost 80 percent of the applicants having a biomedical sciences-related background. Kwan said the programme is very attractive for both overseas and local students. 'This is a shorter programme – four years for them to finish the medical degree – and also gives them a second chance to pursue medicine, as some school leavers at that stage may not have made up their minds,' he said. 'So this provides them with a valuable route if they want to study medicine and become doctors.'
RTHK
2 days ago
- RTHK
Govt seeks to reassure caregivers over trial scheme
Govt seeks to reassure caregivers over trial scheme Chris Sun says caregivers will retain their eligibility for government subsidies when they are hospitalised. Photo: RTHK Welfare chief Chris Sun said low-income caregivers don't need to worry about their subsidy being cut when a trial scheme offering help to them begins on Monday. The trial is part of the government's efforts to build a database for carers, which was first announced in last year's Policy Address. From Monday morning, the Hospital Authority will notify the Social Welfare Department when a caregiver receiving a low-income subsidy needs to spend time in hospital, to see what help they need. Officials will give the family a call or pay a visit, to see if services such as food delivery or respite services are needed. Sun said on a TVB programme on Sunday that while low-income carers need to give at least 80 hours of care a month to receive the subsidy, that requirement will be waived in the case of hospitalisation. "We will handle such cases with discretion - nobody's subsidy will be docked," the minister said. "So for carers, please do not refuse to go to hospital because you worry about the hourly counts affecting your income." Sun added that under the trial scheme, officials will check the address of the caregiver, but not the reason why he or she is hospitalised, or for how many days. The secretary for labour and welfare also said in the long run, the government aims to build a wider net to support caregivers by extending the trial to cover recipients of other government subsidies.
RTHK
4 days ago
- RTHK
CUHK ups hay fever treatment with Chinese medicine
CUHK ups hay fever treatment with Chinese medicine CUHK's research team said nearly 40 percent of trial participants experienced significant improvements in both their symptoms and overall quality of life after using the modified Yu-Ping-Feng powder. Photo: RTHK Researchers at the School of Chinese Medicine at the Chinese University of Hong Kong's Faculty of Medicine say they have enhanced a traditional herbal formula to better alleviate symptoms for hay fever patients. Hay fever, clinically termed allergic rhinitis, is a widespread allergic condition, which triggers frequent sneezing, nasal congestion, itchy eyes and a runny nose. Studies indicate approximately one-quarter of Hong Kong's population suffers from this allergy. Lin Zhixiu, the school's director, said on Friday that the team have modified the traditional Chinese medicine formula "Yu-Ping-Feng" powder by incorporating additional herbs, including magnolia flowers and red reishi mushrooms. He said that hay fever is closely linked to dysfunction in the lungs, spleen and kidneys. He added that the original "Yu-Ping-Feng" formula is commonly used to tonify "qi", the vital energy flowing through the body, in the lungs and spleen, thereby boosting immunity. The research team conducted a clinical study involving 58 allergic rhinitis patients between April 2022 and June 2023. Results demonstrated that after eight weeks of treatment with the modified formula, nearly 40 percent of participants experienced significant improvements in both their symptoms and overall quality of life, the researchers said. "Western drugs primarily work through antihistamine effect so that medicine can help stop sneezing and also runny nose," Lin said. "In Chinese medicine, we primarily try to rebalance the body's functionality by regulating the body's immune system and consolidating the body's skin surface so we can really enhance the body's resistance so that in the future these sort of symptoms will be reduced for a long period of time." Given its effectiveness, Lin believes this modified formula is worth promoting as a valuable alternative therapeutic option for allergic rhinitis patients. "Chinese medicine practitioners can take reference with our trial result and also the composition of this formula in their daily practice," he said. "They can modify this formula to some extent that can suit their own patients more appropriately. "In terms of cost, I believe this herbal formula is not too costly because we primarily use the ordinary herbs into the formula. I think a lot of patients will be able to afford this formula." Lin added that the powder variation is an effective and safe treatment option for those suffering from hay fever.
